Companies are struggling with the form of post-COVID-19 work

to lift social distancing

Domestic corporations "reducing home based on trends

As social distancing measures are lifted in two years, changes are also detected in the pharmaceutical industry.

 

However, telecommuting is unlikely to disappear immediately.

 

As more and more conferences attempt online and offline hybridization this year, they are also cautious about overseas business trips.

 

◆ Maintaining voluntary work for multinational companies, domestic companies are gradually ending telecommuting Since the 18th, all social distancing regulations, including restrictions on the number of private gatherings and business hours, have been lifted.

 

In two years and one month, it has completely shifted to the stage of daily recovery.

 

Telecommuting began in the pharmaceutical industry from early 2020 when COVID-19 began to spread.

 

At that time, only a small number of multinational pharmaceutical companies introduced an autonomous work system that combines home and work.

 

As the spread of COVID-19 spread across the country, domestic companies, led by multinational pharmaceutical companies, also implemented telecommuting.

 

In particular, due to the frequent access to clinics, the pharmaceutical industry began working from home faster than the government.

 

At the end of the distancing measures, many pharmaceutical companies that maintained telecommuting are in the mood to watch the trend more and decide rather than establishing new guidelines immediately.

 

They say that it is too early to be relieved as more than 100,000 COVID-19 confirmed cases are still occurring a day.

 

Multinational pharmaceutical companies that widely utilize telecommuting plan to maintain their current form of autonomous work even after the end of COVID-19.

 

Korean subsidiaries of many multinational pharmaceutical companies, including Pfizer, Amgen, AstraZeneca, Roche, MSD, and Viatris, replied, "The guidelines recommending telecommuting will continue." An official from Viatris Korea said, "Since Omicron mutation became the dominant species, we have been working 100% autonomous for the safety of our employees." "With the government's lifting of social distancing, we will flexibly adjust our telecommuting and commuting two or three times a week in consultation with our manager," he said.

 

An official from Amgen Korea said, "There were no separate guidelines for lifting telecommuting, and executives and employees who need to go to work at the office will continue to go out voluntarily." ◆ International Conference Online and Offline Due to COVID-19, most conferences and conferences have been converted online over the past two years.

 

This year, many academic societies are still taking the form of a hybrid that maintains online or combines online and offline.

 

The JP Morgan Healthcare Conference, which is considered the world's largest pharmaceutical bio investment event, maintained its online format in January.

 

This is because omicron mutations are showing signs of re-proliferation around the world.

 

The AACR held this month was held in person for the first time in three years, but the ASCO, scheduled for June, will be online and offline at the same time.

 

In addition, a number of conferences, including EULAR, ADI Conference, and EHA, will be held both online and offline.

 

Pharmaceutical companies are considering overseas business trips more because there are many conferences that take the form of a hybrid.

 

An official from a multinational pharmaceutical company said, "We are looking at the data to be announced at the ASCO this year, and local participation has not been confirmed.

 

However, as the academic societies also seem to be recovering from their daily lives, we will consider business trips later." Another multinational pharmaceutical company official also said, "We have not decided on an overseas business trip yet," adding, "It is expected to start face-to-face with overseas meetings that are essential." There are still concerns about new variations," he explained.